FAST NEWS: Legend Biotech Plummets on Proposed $300 Million Share Sale
The latest: Biopharmaceutical company Legend Biotech Corp. (LEGN.US) has proposed offering $300 million in American Depositary Shares (ADSs), with the option for underwriters to sell an additional $45 million worth…
